ClinicalTrials.Veeva

Menu

A Prospective Multicenter Randomized Controlled Trial of Flexible And Navigable Suction Ureteral Access Sheath Combined With Needle Perc for the Treatment of Partial Staghorn Renal Calculi

B

Beijing Tsinghua Chang Gung Hospital

Status

Not yet enrolling

Conditions

Urinary Calculi

Treatments

Procedure: PCNL
Procedure: Performed flexible and navigable suction ureteral access sheath combined with needle perc

Study type

Interventional

Funder types

Other

Identifiers

NCT06914986
24747-0-02

Details and patient eligibility

About

The goal of this clinical trial is to learn if flexible and navigable suction ureteral access sheath combined with needle perc works to treat partial staghorn renal calculi. It will also learn about the safety of drug ABC. The main questions it aims to answer are:

  • Does flexible and navigable suction ureteral access sheath combined with needle perc result in similar stone free rate compared with PCNL
  • Does flexible and navigable suction ureteral access sheath combined with needle perc result in more complications compared with PCNL Researchers will compare flexible and navigable suction ureteral access sheath combined with needle perc result in similar stone free rate compared with PCNL to see if flexible and navigable suction ureteral access sheath combined with needle perc works to treat partial staghorn renal calculi.

Participants will:

  • Performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
  • Visit the clinic after surgery 1 month and 3 month for checkups and tests

Enrollment

344 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18-80 years
  2. CT scan indicates partial staghorn calculi
  3. Able to complete the study in accordance with the protocol requirements
  4. Informed about the study and has signed the informed consent form

Exclusion criteria

  1. Severe renal insufficiency (GFR < 30 ml/min/1.73 m²)
  2. Significant calyceal hydronephrosis (calyceal width ≥ 2 cm)
  3. Renal stone volume > 33.5 cm³
  4. Renal stones or nephrocalcinosis caused by genetic diseases or definite metabolic disorders that have not been ruled out, such as renal tubular acidosis, primary hyperoxaluria, primary hyperparathyroidism, etc.
  5. Congenital or structural renal abnormalities: spinal deformity, ankylosing spondylitis, horseshoe kidney, medullary sponge kidney, duplicated kidney, polycystic kidney, ectopic kidney, etc.
  6. History of previous open renal stone surgery
  7. Patients with uncontrolled urinary tract infections
  8. Subjects deemed by the investigator to have other factors that make them unsuitable for participation in this trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

344 participants in 2 patient groups

flexible and navigable suction ureteral access sheath combined with needle perc
Experimental group
Treatment:
Procedure: Performed flexible and navigable suction ureteral access sheath combined with needle perc
PCNL group
Other group
Treatment:
Procedure: PCNL

Trial contacts and locations

0

Loading...

Central trial contact

bo xiao, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems